BlueRock Therapeutics Claimed Company
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
read more
Great. The company is evolving, but seems to be managing well through the changes, which hopefully translates to a bright future at BlueRock
What is most positive about the culture and environment at your company?
Collaboration and excitement about the corporate mission and science
What is the best part about your compensation package?
It is fair and meets industry standards on base comp.
What do you like best about the leadership team?
The leadership team is supportive and transparent in communicating to the broader organization
What makes you most happy at work?
The people. People are honest, transparent and collaborative. They appreciate differences and recognize that everyone has been hired to bring a unique skill set and perspective to the team. People are valued.
What are some of the best things about your team?
People are engaging and enthusiastic about what we are doing at BlueRock. BlueRock fosters a collaborative environment as we are all working towards the same goal of brining innovative cell therapies to patients
Other Employee Reviews for BlueRock Therapeutics
×